144 related articles for article (PubMed ID: 32317978)
1. Spadin Selectively Antagonizes Arachidonic Acid Activation of TREK-1 Channels.
Ma R; Lewis A
Front Pharmacol; 2020; 11():434. PubMed ID: 32317978
[TBL] [Abstract][Full Text] [Related]
2. Spadin as a new antidepressant: absence of TREK-1-related side effects.
Moha Ou Maati H; Veyssiere J; Labbal F; Coppola T; Gandin C; Widmann C; Mazella J; Heurteaux C; Borsotto M
Neuropharmacology; 2012 Jan; 62(1):278-88. PubMed ID: 21807005
[TBL] [Abstract][Full Text] [Related]
3. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid hyperpolarizes mesenchymal stromal cells from the human adipose tissue by stimulating TREK1 K
Tarasov MV; Kotova PD; Bystrova MF; Kabanova NV; Sysoeva VY; Kolesnikov SS
Channels (Austin); 2019 Dec; 13(1):36-47. PubMed ID: 30661462
[TBL] [Abstract][Full Text] [Related]
5. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
[TBL] [Abstract][Full Text] [Related]
6. Shortened Spadin Analogs Display Better TREK-1 Inhibition,
Djillani A; Pietri M; Moreno S; Heurteaux C; Mazella J; Borsotto M
Front Pharmacol; 2017; 8():643. PubMed ID: 28955242
[TBL] [Abstract][Full Text] [Related]
7. First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides.
Pietri M; Djillani A; Mazella J; Borsotto M; Heurteaux C
Neuropharmacology; 2019 Nov; 158():107715. PubMed ID: 31325429
[TBL] [Abstract][Full Text] [Related]
8. TREK-1 Channel Expression in Smooth Muscle as a Target for Regulating Murine Intestinal Contractility: Therapeutic Implications for Motility Disorders.
Ma R; Seifi M; Papanikolaou M; Brown JF; Swinny JD; Lewis A
Front Physiol; 2018; 9():157. PubMed ID: 29563879
[TBL] [Abstract][Full Text] [Related]
9. Spadin Modulates Astrocytic Passive Conductance via Inhibition of TWIK-1/TREK-1 Heterodimeric Channels.
Bae Y; Choi JH; Ryoo K; Kim A; Kwon O; Jung HG; Hwang EM; Park JY
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348878
[TBL] [Abstract][Full Text] [Related]
10. The peptidic antidepressant spadin interacts with prefrontal 5-HT(4) and mGluR(2) receptors in the control of serotonergic function.
Moha ou Maati H; Bourcier-Lucas C; Veyssiere J; Kanzari A; Heurteaux C; Borsotto M; Haddjeri N; Lucas G
Brain Struct Funct; 2016 Jan; 221(1):21-37. PubMed ID: 25233810
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine Protection in Decompression Sickness in Mice is Enhanced by Blocking TREK-1 Potassium Channel with the "spadin" Antidepressant.
Vallée N; Lambrechts K; De Maistre S; Royal P; Mazella J; Borsotto M; Heurteaux C; Abraini J; Risso JJ; Blatteau JE
Front Physiol; 2016; 7():42. PubMed ID: 26909044
[TBL] [Abstract][Full Text] [Related]
12. The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension.
Csáki R; Nagaraj C; Almássy J; Khozeimeh MA; Jeremic D; Olschewski H; Dobolyi A; Hoetzenecker K; Olschewski A; Enyedi P; Lengyel M
Br J Pharmacol; 2024 May; ():. PubMed ID: 38807478
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of SKCa and TREK1 channels in purinergic and nitrergic neuromuscular transmission in the rat colon.
Gil V; Gallego D; Moha Ou Maati H; Peyronnet R; Martínez-Cutillas M; Heurteaux C; Borsotto M; Jiménez M
Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G412-23. PubMed ID: 22636169
[TBL] [Abstract][Full Text] [Related]
14. Retroinverso analogs of spadin display increased antidepressant effects.
Veyssiere J; Moha Ou Maati H; Mazella J; Gaudriault G; Moreno S; Heurteaux C; Borsotto M
Psychopharmacology (Berl); 2015 Feb; 232(3):561-74. PubMed ID: 25080852
[TBL] [Abstract][Full Text] [Related]
15. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin.
Djillani A; Pietri M; Mazella J; Heurteaux C; Borsotto M
Pharmacol Ther; 2019 Feb; 194():185-198. PubMed ID: 30291907
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of TREK-TRAAK K
Zhang XT; Xu Z; Shi KP; Guo DL; Li H; Wang L; Zhu XB
Int J Ophthalmol; 2019; 12(6):924-929. PubMed ID: 31236347
[TBL] [Abstract][Full Text] [Related]
17. Properties of single two-pore domain TREK-2 channels expressed in mammalian cells.
Kang D; Choe C; Cavanaugh E; Kim D
J Physiol; 2007 Aug; 583(Pt 1):57-69. PubMed ID: 17540699
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin.
Devader C; Khayachi A; Veyssière J; Moha Ou Maati H; Roulot M; Moreno S; Borsotto M; Martin S; Heurteaux C; Mazella J
Br J Pharmacol; 2015 May; 172(10):2604-17. PubMed ID: 25598009
[TBL] [Abstract][Full Text] [Related]
19. AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels.
Sandoz G; Thümmler S; Duprat F; Feliciangeli S; Vinh J; Escoubas P; Guy N; Lazdunski M; Lesage F
EMBO J; 2006 Dec; 25(24):5864-72. PubMed ID: 17110924
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
